EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis

Vandita Kakkar, Komal Saini, Kamalinder K Singh

Pharmacological Reports · 2023-10 · 75 (5) · 1066-1095

DOI: 10.1007/s43440-023-00510-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reports, online erschienen am 05.09.2023. Verfasst von Vandita Kakkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. vanditakakkar@yahoo.co.in. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a predominant and deteriorating chronic inflammation of the skin, categorized by a burning sensation and eczematous lesions in diverse portions of the body. The treatment of AD is exclusively focused to limit the itching, reduce inflammation, and repair the breached barrier of the skin. Several therapeutic agents for the treatment and management of AD have been reported and are in use in clinics. However, the topical treatment of AD has been an unswerving challenge for the medical fraternity owing to the impaired skin barrier function in this chronic skin condition. To surmount the problems of conventional drug delivery systems, numerous nanotechnology-based formulations are emerging as alternative new modalities for AD. Latter enhances the bioavailability and delivery to the target disease site, improves drug permeation and therapeutic efficacy with reduced systemic and off-target side effects, and thus improves patient health and promotes compliance. This review aims to describe the various pathophysiological events involved in the occurrence of AD, current challenges in treatment, evidence of molecular markers of AD and its management, combinatorial treatment options, and the intervention of nanotechnology-based formulations for AD therapeutics. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansAdministration, CutaneousSkinDrug Delivery SystemsInflammation

Stichwörter der Autor:innen

Atopic dermatitisNanoformulationNanoparticlesSafety aspectsSkin penetrationTopical delivery

Autor:innen und Institutionen

  • Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. vanditakakkar@yahoo.co.in.
  • Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India.
  • School of Pharmacy and Biomedical Sciences, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire, Preston, PR1 2HE, Lancashire, UK.
  • School of Pharmacy and Biomedical Sciences, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire, Preston, PR1 2HE, Lancashire, UK. ksingh1@uclan.ac.uk.
  • UCLan Research Centre for Smart Materials, University of Central Lancashire, Preston, PR1 2HE, Lancashire, UK. ksingh1@uclan.ac.uk.
  • UCLan Research Centre for Translational Biosciences and Behaviour, University of Central Lancashire, Preston, PR1 2HE, Lancashire, UK. ksingh1@uclan.ac.uk.

Zitieren

APA

Kakkar, V., Saini, K., & Singh, K. K. (2023). Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis. Pharmacological Reports, 75(5), 1066-1095. https://doi.org/10.1007/s43440-023-00510-3

Vancouver

Kakkar V, Saini K, Singh KK. Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis. Pharmacological Reports. 2023;75(5):1066-1095. doi:10.1007/s43440-023-00510-3

BibTeX
@article{Kakkar2023,
  author = {Kakkar, Vandita and Saini, Komal and Singh, Kamalinder K},
  title = {Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis},
  journal = {Pharmacological Reports},
  year = {2023},
  volume = {75},
  number = {5},
  pages = {1066--1095},
  doi = {10.1007/s43440-023-00510-3}
}
Kostenlos starten →